{"id":"NCT03882047","sponsor":"Organon and Co","briefTitle":"Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE速 in Seasonal Allergic Rhinitis Patients (I94-001)","officialTitle":"Efficacy and Safety of Mometasone Furoate Aqueous Nasal Spray vs Placebo and Flonase速 (Fluticasone Propionate) in Seasonal Allergic Rhinitis Patients (I94-001)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"1994-08-11","primaryCompletion":"1994-09-16","completion":"1994-09-16","firstPosted":"2019-03-20","resultsPosted":"2019-09-06","lastUpdate":"2022-02-09"},"enrollment":313,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Rhinitis, Allergic, Seasonal"],"interventions":[{"type":"DRUG","name":"Mometasone furoate","otherNames":["NASONEX速","MK-0887","SCH 032088"]},{"type":"DRUG","name":"Fluticasone propionate","otherNames":["FLONASE速"]},{"type":"DRUG","name":"Mometasone furoate placebo","otherNames":[]},{"type":"DRUG","name":"Fluticasone propionate placebo","otherNames":[]}],"arms":[{"label":"Mometasone furoate nasal spray","type":"EXPERIMENTAL"},{"label":"Fluticasone propionate nasal spray","type":"ACTIVE_COMPARATOR"},{"label":"Placebo nasal spray","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of mometasone furoate (SCH 32088) aqueous nasal spray 200 mcg once daily compared to placebo once daily in the treatment of participants with seasonal allergic rhinitis. Flonase (fluticasone propionate) nasal spray 200 mcg once daily has been chosen as the active control for this study.","primaryOutcome":{"measure":"Change From Baseline in Total Nasal Symptom Score Averaged Over Day 1 Through Day 15 (Based on Participant Diaries)","timeFrame":"Baseline and Day 1 through Day 15 (averaged over 15 days)","effectByArm":[{"arm":"Mometasone Furoate Nasal Spray","deltaMin":-2.8,"sd":2.2},{"arm":"Fluticasone Propionate Nasal Spray","deltaMin":-3.4,"sd":2.3},{"arm":"Placebo Nasal Spray","deltaMin":-0.9,"sd":2.3}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.01"},{"comp":"OG001 vs OG002","p":"<0.01"},{"comp":"OG000 vs OG001","p":"0.03"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":14},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":104},"commonTop":["HEADACHE","COUGH","NASAL DISCOMFORT","OROPHARYNGEAL PAIN","FATIGUE"]}}